1. Home
  2. RCKT vs MTAL Comparison

RCKT vs MTAL Comparison

Compare RCKT & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • MTAL
  • Stock Information
  • Founded
  • RCKT 1999
  • MTAL 2021
  • Country
  • RCKT United States
  • MTAL Jersey
  • Employees
  • RCKT N/A
  • MTAL N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • MTAL Blank Checks
  • Sector
  • RCKT Health Care
  • MTAL Finance
  • Exchange
  • RCKT Nasdaq
  • MTAL Nasdaq
  • Market Cap
  • RCKT 764.5M
  • MTAL 690.2M
  • IPO Year
  • RCKT N/A
  • MTAL 2021
  • Fundamental
  • Price
  • RCKT $6.99
  • MTAL $9.61
  • Analyst Decision
  • RCKT Strong Buy
  • MTAL Buy
  • Analyst Count
  • RCKT 10
  • MTAL 2
  • Target Price
  • RCKT $43.90
  • MTAL $14.75
  • AVG Volume (30 Days)
  • RCKT 3.1M
  • MTAL 398.8K
  • Earning Date
  • RCKT 05-08-2025
  • MTAL 04-29-2025
  • Dividend Yield
  • RCKT N/A
  • MTAL N/A
  • EPS Growth
  • RCKT N/A
  • MTAL N/A
  • EPS
  • RCKT N/A
  • MTAL N/A
  • Revenue
  • RCKT N/A
  • MTAL $340,736,000.00
  • Revenue This Year
  • RCKT N/A
  • MTAL $21.74
  • Revenue Next Year
  • RCKT N/A
  • MTAL $19.03
  • P/E Ratio
  • RCKT N/A
  • MTAL N/A
  • Revenue Growth
  • RCKT N/A
  • MTAL 114.30
  • 52 Week Low
  • RCKT $4.55
  • MTAL $7.69
  • 52 Week High
  • RCKT $26.98
  • MTAL $15.26
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 48.90
  • MTAL 56.65
  • Support Level
  • RCKT $6.21
  • MTAL $8.61
  • Resistance Level
  • RCKT $8.26
  • MTAL $9.66
  • Average True Range (ATR)
  • RCKT 0.54
  • MTAL 0.37
  • MACD
  • RCKT 0.03
  • MTAL 0.10
  • Stochastic Oscillator
  • RCKT 38.05
  • MTAL 90.45

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About MTAL Metals Acquisition Limited

MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.

Share on Social Networks: